April 2025

A listing of the individual articles included in the Jurisdiction F Medicare A News bulletin dated April 2025 is provided. Each article title functions as a hyperlink to a specific article.

paginationType regular
Articles Source
2025 CPT/HCPCS Billing and Coding Article Updates
2025 MolDX CPT/HCPCS Billing and Coding Article Updates - Effective January 1, 2025
Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) - Published for Review and Comments
April 2025 CPT/HCPCS Billing and Coding Article Updates
Billing and Coding: Cervical Fusion (A59645) - R3 - Effective July 7, 2024
Billing and Coding: Diagnostic and Therapeutic Colonoscopy (A57343)- R6 - Effective October 1, 2024
Billing and Coding: Epidural Steroid Injections for Pain Management (A58995) - R4 - Effective June 19, 2022
Billing and Coding: Guardant360® (A58214) Retirement - Effective December 25, 2022
Billing and Coding: Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnea (A57949) - R4 - Effective December 1, 2024
Billing and Coding: Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnea (A57949) - R4 - Effective December 1, 2024
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55323) - R19 - Effective January 1, 2025
Billing and Coding: Intraocular Bevacizumab (A53009) - R17 - Effective January 1, 2025
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58456) - R9 - Effective November 18, 2024
Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (A58724)- R5 - Effective September 11, 2024
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57527)- R21 - Effective January 1, 2025
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58726)- R23 - Effective January 1, 2025
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58726)- R24- Effective March 13, 2025
Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (A58975)- R6 - Effective January 1, 2025
Billing and Coding: Peripheral Nerve Stimulation (A55531) - R10 - Effective August 27, 2018
Billing and Coding: Trigger Point Injections (TPI) (A57702) - R6 - Effective April 1, 2024
Billing Instructions: Expedited Determinations Based on Medicare Change of Status Notifications CR13918
CLFS & Laboratory Services Subject to Reasonable Charge Payment: April 2025 Quarterly Update CR13966
Clinical Laboratory Fee Schedule: 2025 Annual Update CR13889
CMS Telehealth Frequently Asked Questions (FAQ)
COBA Crossover Letters Available on NMP
ESRD Treatment Choices (ETC) Model Mass Adjustments - Resolved 02/12/25 Alert
Federally Qualified Health Center (FQHC) MAC Assignment
HCPCS Codes Used for SNF CB Enforcement: April 2025 Quarterly Update CR13945
Holding Claims for Pricing Based on the April 2025 FISS Release
Hospital OPPS: January 2025 Update CR13933
How to Use the Office & Outpatient Evaluation and Management Visit Complexity Add-on Code G2211 - Revised CR13473
Hyperbaric Oxygen Therapy (HBO) for Diabetic Wounds
Initial Certification and Recertification Outpatient Therapy - New Exception
Intervertebral Disc Repair Final LCD - Effective April 13, 2025
January 2025 Quarterly ASP Medicare Part B Drug Pricing Files and Revisions to Prior Quarterly Pricing Files CR13802
Medical Records Requirements for Redetermination
Medicare Diabetes Prevention Program (MDPP) 2025 Changes
Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ) Final LCD - Effective February 16, 2025
MLN Connects - February 14, 2025
MLN Connects - February 24, 2025
MLN Connects - February 28, 2025
MLN Connects - January 16, 2025
MLN Connects - January 8, 2025
MLN Connects - March 13, 2025
MLN Connects - March 25, 2025
MLN Connects - March 27, 2025
MLN Connects - March 6, 2025
MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (L39003) - R3 - Effective January 30, 2025
MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia (L39264) - R1 - Effective March 13, 2025
MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules (L39684) - R1 - Effective March 13, 2025
— 50 Resultados por página
Mostrando el intervalo 1 - 50 de 70 resultados.